1-21889786-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005529.7(HSPG2):c.574+195G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.31 in 630,300 control chromosomes in the GnomAD database, including 31,697 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.28 ( 6637 hom., cov: 32)
Exomes 𝑓: 0.32 ( 25060 hom. )
Consequence
HSPG2
NM_005529.7 intron
NM_005529.7 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.72
Publications
11 publications found
Genes affected
HSPG2 (HGNC:5273): (heparan sulfate proteoglycan 2) This gene encodes the perlecan protein, which consists of a core protein to which three long chains of glycosaminoglycans (heparan sulfate or chondroitin sulfate) are attached. The perlecan protein is a large multidomain proteoglycan that binds to and cross-links many extracellular matrix components and cell-surface molecules. It has been shown that this protein interacts with laminin, prolargin, collagen type IV, FGFBP1, FBLN2, FGF7 and transthyretin, etc., and it plays essential roles in multiple biological activities. Perlecan is a key component of the vascular extracellular matrix, where it helps to maintain the endothelial barrier function. It is a potent inhibitor of smooth muscle cell proliferation and is thus thought to help maintain vascular homeostasis. It can also promote growth factor (e.g., FGF2) activity and thus stimulate endothelial growth and re-generation. It is a major component of basement membranes, where it is involved in the stabilization of other molecules as well as being involved with glomerular permeability to macromolecules and cell adhesion. Mutations in this gene cause Schwartz-Jampel syndrome type 1, Silverman-Handmaker type of dyssegmental dysplasia, and tardive dyskinesia. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]
HSPG2 Gene-Disease associations (from GenCC):
- Schwartz-Jampel syndrome type 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
- Silverman-Handmaker type dyssegmental dysplasiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
- Schwartz-Jampel syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 1-21889786-C-T is Benign according to our data. Variant chr1-21889786-C-T is described in ClinVar as Benign. ClinVar VariationId is 1293470.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.378 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| HSPG2 | ENST00000374695.8 | c.574+195G>A | intron_variant | Intron 6 of 96 | 1 | NM_005529.7 | ENSP00000363827.3 | |||
| HSPG2 | ENST00000374673.4 | c.328+195G>A | intron_variant | Intron 3 of 6 | 3 | ENSP00000497688.1 | ||||
| HSPG2 | ENST00000412328.5 | n.342+195G>A | intron_variant | Intron 3 of 5 | 2 | |||||
| HSPG2 | ENST00000439717.2 | n.*30G>A | downstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.283 AC: 42994AN: 151900Hom.: 6632 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
42994
AN:
151900
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.319 AC: 152376AN: 478280Hom.: 25060 Cov.: 5 AF XY: 0.318 AC XY: 79840AN XY: 251378 show subpopulations
GnomAD4 exome
AF:
AC:
152376
AN:
478280
Hom.:
Cov.:
5
AF XY:
AC XY:
79840
AN XY:
251378
show subpopulations
African (AFR)
AF:
AC:
2222
AN:
13080
American (AMR)
AF:
AC:
9428
AN:
20938
Ashkenazi Jewish (ASJ)
AF:
AC:
3314
AN:
14174
East Asian (EAS)
AF:
AC:
12321
AN:
31084
South Asian (SAS)
AF:
AC:
14703
AN:
46386
European-Finnish (FIN)
AF:
AC:
15263
AN:
44178
Middle Eastern (MID)
AF:
AC:
962
AN:
3562
European-Non Finnish (NFE)
AF:
AC:
86161
AN:
278048
Other (OTH)
AF:
AC:
8002
AN:
26830
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
5128
10256
15384
20512
25640
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
580
1160
1740
2320
2900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.283 AC: 43011AN: 152020Hom.: 6637 Cov.: 32 AF XY: 0.286 AC XY: 21235AN XY: 74310 show subpopulations
GnomAD4 genome
AF:
AC:
43011
AN:
152020
Hom.:
Cov.:
32
AF XY:
AC XY:
21235
AN XY:
74310
show subpopulations
African (AFR)
AF:
AC:
7143
AN:
41476
American (AMR)
AF:
AC:
5902
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
785
AN:
3470
East Asian (EAS)
AF:
AC:
1954
AN:
5146
South Asian (SAS)
AF:
AC:
1435
AN:
4818
European-Finnish (FIN)
AF:
AC:
3503
AN:
10566
Middle Eastern (MID)
AF:
AC:
71
AN:
294
European-Non Finnish (NFE)
AF:
AC:
21205
AN:
67956
Other (OTH)
AF:
AC:
587
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1531
3062
4592
6123
7654
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
446
892
1338
1784
2230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1108
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Aug 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.